Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) SHZ
5.19
-0.1(-1.89%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Chongqing Lummy Pharmaceutical Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1019
First IPO Date
October 30, 2009
Key Executives
| Name | Title | Pay | Year Born |
| Song Lin | Deputy GM & Director | 0 | 1973 |
| Ruoyue Wang | Deputy GM & GM of Chemical Pharmaceutical Division | 0 | 1959 |
| Rongzhao Qiu | General Manager | 0 | 1994 |
| Dan Cui | Deputy GM, Secretary & General Counsel | 0 | 1980 |
| Xue Feng Leng | Deputy GM & Vice Chairman | 0 | 1972 |
| Wen Lai | Financial Director | 0 | 1974 |
Description
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
